Huffington Post features CN Bio CEO:

Women in Innovation: Developing ‘Organs-on-Chips’

Interview clip:

“My background as a chemist means that I like precision. However, drug development is not nearly as logical as we’d like. Profound uncertainty about the likely success of drug programs can persist into late stage clinical trials – by which time millions of pounds will have already been spent. At CN Bio we were determined to find a better way, a way of modelling how a drug would work on human cells which could be safely tested in a laboratory setting.”

← Back To All News